Molecular Insights Into μ Opioid Pharmacology
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 26 (Supplement) , S3-S9
Abstract
Most of the opioids used in clinical practice exert their effects through μ opioid receptors. Yet, subtle but important pharmacological differences have been observed among the μ opioids. Their potency, effectiveness, and adverse effects can vary unpredictably among patients. These clinical differences among the μ opioids strongly argue against a single receptor mediating their actions. The cloning of the μ opioid receptor has greatly enhanced our understanding of the complexity of this system and has provided possible mechanisms to explain these observations. A single μ opioid receptor gene has been identified, but we now know that it generates a multitude of different μ opioid receptor subtypes through a mechanism commonly used to enhance protein diversity, alternative splicing. Early studies identified a number of splice variants involving the tip of the C-terminus. This region of the receptor is far away from the binding pocket, explaining why these variants still exhibit the same selectivity for μ opioids. However, the differences in structure at the C-terminus influence the activation patterns of the μ opioids. In addition, a second series of variants has been isolated that involves alternative splicing at the N-terminus. Together, these sets of μ opioid receptor splice variants may help explain the clinical variability of the μ drugs among patients and provide insights into why it is so important to individualize therapy for every patient in pain.Keywords
This publication has 35 references indexed in Scilit:
- Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actionsProceedings of the National Academy of Sciences, 2009
- Splice-site pairing is an intrinsically high fidelity processProceedings of the National Academy of Sciences, 2009
- Isolation and characterization of new exon 11‐associated N‐terminal splice variants of the human mu opioid receptor geneJournal of Neurochemistry, 2009
- Expansion of the human μ-opioid receptor gene architecture: novel functional variantsHuman Molecular Genetics, 2008
- Evolution of vertebrate opioid receptorsProceedings of the National Academy of Sciences, 2008
- Molecular Biology of Opioid AnalgesiaJournal of Pain and Symptom Management, 2005
- Finishing the euchromatic sequence of the human genomeNature, 2004
- Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesiaNeuroscience Letters, 1996
- Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion modelLife Sciences, 1989
- Morphine-6-glucuronide, a potent mu agonistLife Sciences, 1987